Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

      Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

      Medical Dialogues Bureau9 Oct 2019 4:24 PM IST
      Johnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
      Glenmark gets tentative USFDA nod for generic version of Tecfidera Capsules

      Glenmark gets tentative USFDA nod for generic version of Tecfidera Capsules

      Medical Dialogues Bureau9 Oct 2019 12:19 PM IST
      "According to IQVIATM sales data for the 12 month period ending August 2019, the Tecfidera Capsules, 120 mg and 240 mg market2 achieved annual sales...
      Bliss GVS Pharma arm clears USFDA inspection of Ambernath facility

      Bliss GVS Pharma arm clears USFDA inspection of Ambernath facility

      Medical Dialogues Bureau9 Oct 2019 9:45 AM IST
      "The successful audit outcome from USFDA is a reflection of the steady progress that we are making into the mature pharma markets," Bliss GVS Pharma...
      Fight against Rabies: India hands over 10k vials of anti-rabies vaccines to Myanmar

      Fight against Rabies: India hands over 10k vials of anti-rabies vaccines to Myanmar

      Medical Dialogues Bureau9 Oct 2019 9:35 AM IST
      In a handing over ceremony held in Yangon on Tuesday, the Deputy Chief of Mission Sumit Seth handed over the vials of Anti-Rabies Vaccines to...
      Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

      Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

      Medical Dialogues Bureau9 Oct 2019 9:30 AM IST
      GSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
      Regulatory interventions constraining Profitability of Indian pharma: ICRA

      Regulatory interventions constraining Profitability of Indian pharma: ICRA

      Medical Dialogues Bureau8 Oct 2019 4:53 PM IST
      "But revenues continue to be impacted by price erosion, product rationalisation and continued effect of regulatory overhang for certain companies...
      Glenmark shares fall 9pc on USFDA warning letter for Baddi facility

      Glenmark shares fall 9pc on USFDA warning letter for Baddi facility

      Medical Dialogues Bureau8 Oct 2019 3:08 PM IST
      Drug firm Glenmark Pharmaceuticals on Saturday said it has received a warning letter from the United States Food and Drug Administration (USFDA) for...
      Aurobindo Pharma Unit-7 gets 7 USFDA observations

      Aurobindo Pharma Unit-7 gets 7 USFDA observations

      Medical Dialogues Bureau8 Oct 2019 2:54 PM IST
      The United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
      Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

      Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

      Medical Dialogues Bureau8 Oct 2019 9:50 AM IST
      "We are planning an investment of around Rs 50 crore for setting up an advanced cancer care unit, an additional cath lab as well as an IVF unit in the...
      Shilpa Medicare gets final USFDA approval for Gemcitabine Injection

      Shilpa Medicare gets final USFDA approval for Gemcitabine Injection

      Medical Dialogues Bureau8 Oct 2019 9:45 AM IST
      Gemcitabine Injection is used in the treatment of Ovarian Cancer, Breast Cancer, Non-Small Cell Lung Cancer and Pancreatic Cancer as recommended in...
      Takeda Pharma, Prometheus Biosciences collaborate to develop therapies for IBD

      Takeda Pharma, Prometheus Biosciences collaborate to develop therapies for IBD

      Medical Dialogues Bureau8 Oct 2019 9:15 AM IST
      Under the terms of the agreement, Prometheus Biosciences will receive an undisclosed initial upfront payment from Takeda and is eligible to receive up...
      Dr Reddys gets Establishment Inspection Report from USFDA for Bollaram facility

      Dr Reddys gets Establishment Inspection Report from USFDA for Bollaram facility

      Medical Dialogues Bureau7 Oct 2019 2:28 PM IST
      New Delhi: Hyderabad-based drug major, Dr Reddy's Laboratories has received an Establishment Inspection Report (EIR) from the US Health regulator for...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok